We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Lyft
LYFT
$5.73B
| $3.17M | 0.02% |
+52,330
| New | +$3.01M |
|
527
Quanex
NX
$863M
| $3.15M | 0.02% |
126,989
-67,647
| -35% | -$1.8M |
|
528
Merchants Bancorp
MBIN
$2.22B
| $3.15M | 0.02% |
120,492
+6,649
| +6% | +$184K |
|
529
Avista
AVA
$3.43B
| $3.15M | 0.02% |
73,857
-995
| -1% | -$45.6K |
|
530
Central Pacific Financial
CPF
$1.01B
| $3.1M | 0.02% |
119,131
| – | – |
|
|
TECX
531
Tectonic Therapeutic
TECX
$578M
| $3.05M | 0.02% |
28,574
-71
| -0.2% | -$8.42K |
|
532
Live Oak Bancshares
LOB
$1.95B
| $3.04M | 0.02% |
51,522
+1,131
| +2% | +$71K |
|
533
BlueLinx
BXC
$453M
| $3.02M | 0.02% |
59,966
+31,955
| +114% | +$1.57M |
|
534
Powell Industries
POWL
$7.99B
| $3.02M | 0.02% |
292,233
+11,352
| +4% | +$131K |
|
|
PRA
535
DELISTED
ProAssurance
PRA
| $2.98M | 0.02% |
130,977
+38,590
| +42% | +$972K |
|
536
Nicolet Bankshares
NIC
$3.54B
| $2.96M | 0.02% |
42,115
+9,618
| +30% | +$750K |
|
537
Tilly's
TLYS
$117M
| $2.95M | 0.02% |
184,580
+11,777
| +7% | +$159K |
|
|
HONE
538
DELISTED
HarborOne Bancorp
HONE
| $2.91M | 0.02% |
203,028
+139,890
| +222% | +$2.02M |
|
539
CNX Resources
CNX
$4.77B
| $2.87M | 0.02% |
210,333
+89,342
| +74% | +$1.25M |
|
540
Insight Enterprises
NSIT
$3.71B
| $2.83M | 0.02% |
28,313
+8,927
| +46% | +$902K |
|
|
DCPH
541
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.8M | 0.02% |
76,572
-35,411
| -32% | -$1.37M |
|
|
MTOR
542
DELISTED
MERITOR, Inc.
MTOR
| $2.8M | 0.02% |
+119,469
| New | +$3.14M |
|
|
ACBI
543
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $2.79M | 0.02% |
109,375
+5,972
| +6% | +$158K |
|
544
Matrix Service
MTRX
$347M
| $2.73M | 0.02% |
259,739
-9,257
| -3% | -$112K |
|
545
Waterstone Financial
WSBF
$363M
| $2.72M | 0.02% |
138,520
+78,327
| +130% | +$1.57M |
|
546
Allison Transmission
ALSN
$10.1B
| $2.7M | 0.02% |
67,943
-20,451
| -23% | -$870K |
|
547
Palo Alto Networks
PANW
$259B
| $2.68M | 0.02% |
43,350
-153,234
| -78% | -$9.08M |
|
548
Rayonier Advanced Materials
RYAM
$573M
| $2.65M | 0.02% |
396,758
+169,415
| +75% | +$1.38M |
|
549
Prosperity Bancshares
PB
$8.69B
| $2.65M | 0.02% |
36,890
-16,705
| -31% | -$1.25M |
|
550
NVIDIA
NVDA
$4.76T
| $2.63M | 0.02% |
+131,400
| New | +$2.11M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.